Modulation of TRPV4-mediated TNF-α expression in Müller glia and subsequent RGC apoptosis by statins

• Published in: Experimental eye research Vol. 239; p. 109781
• Main Authors: Choi, Go Woon, Kim, Mi-Lyang, Sung, Kyung Rim
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-02-2024
• Subjects: Müller cells; Retinal ganglion cells (RGCs); Statins; Transient receptor potential vanilloid 4 (TRPV4); Tumor necrosis factor-alpha (TNF-α); Transient receptor potential vanilloid 4 (TRPV4); Tumor necrosis factor-alpha (TNF-α); Müller cells; Statins; Retinal ganglion cells (RGCs)
• ISSN: 0014-4835; 1096-0007
• DOI: 10.1016/j.exer.2024.109781

In addition to regulating cholesterol synthesis, statins have neuroprotective effects. Apoptosis of retinal ganglion cells (RGCs) causes a gradual loss of visual function in glaucoma. This study aimed to investigate the neuroprotective effect of statins on the RGC apoptosis induced by activated Müller glia. Primary Müller cells and RGCs were cultured from the retina of C57BL6 mice. Müller cells were activated with GSK101, a transient receptor potential vanilloid 4 (TRPV4) agonist, and tumor necrosis factor-alpha (TNF-α) released to the medium was measured using an enzyme-linked immunosorbent assay. Cells were pretreated with simvastatin or lovastatin before GSK101. RGCs were treated with conditioned media from Müller glia cultures, and apoptosis was determined using flow cytometry. TRPV4 activation through GSK101 treatment induced gliosis of Müller cells, and the conditioned media from activated Müller cells was potent to induce RGC apoptosis. Statins suppress both gliosis in Müller cells and subsequent RGC apoptosis. TNF-α release to the media was increased in GSK101-treated Müller cells, and TNF-α in the conditioned media was the critical factor causing RGC apoptosis. The increase in TRPV4-mediated TNF-α expression occurred through the nuclear factor kappa-light chain enhancer of activated B cell pathway activation, which was inhibited by statins. Herein, we showed that statins can modulate gliosis and TNF-α expression in Müller cells, protecting RGCs. These data further support the neuroprotective effect of statins, promoting them as a potential treatment for glaucoma.